Cipla: Cipla gets USFDA nod for generic cancer drug
Cipla receives USFDA approval for paclitaxel protein-bound particles for injectable suspension (albumin-bound), 100 mg/vial, single-dose vial
Read full article »
Cipla develops and produces drugs for the treatment of arthritis, diabetes, weight control, depression and cardiovascular diseases.
Read more